picornavirus
includ
human
rhinovirus
hrv
enterovirus
ev
frequent
caus
acut
human
ill
worldwid
hrv
preval
caus
acut
respiratori
tract
ill
ari
usual
commenc
upper
respiratori
tract
urt
ari
lead
caus
morbid
children
year
occur
season
ari
link
hrv
infect
associ
excess
perhap
inappropri
antibiot
prescrib
signific
direct
indirect
healthcar
expenditur
ari
incid
highest
first
year
life
episod
per
year
includ
six
posit
hrv
uncommon
averag
one
infect
per
childmonth
preschoolag
children
nearli
gener
practition
visit
ari
mani
selflimit
ari
often
manag
commun
support
care
parent
complic
aris
requir
medic
visit
manag
asthma
otiti
media
sinus
hrv
replic
nasal
cell
sinu
cell
bronchial
epitheli
cell
bec
smooth
muscl
cell
monocyt
dendrit
cell
dc
inflammatori
immun
respons
trigger
soon
infect
greatest
impact
young
elderli
asthma
chronic
obstruct
pulmonari
diseas
copd
immunocompromis
first
infect
usual
elicit
stronger
respons
antivir
intervent
develop
decad
date
met
vari
degre
failur
unaccept
vaccin
consid
unachiev
larg
number
divers
distinct
viral
type
classic
defin
recogn
hrv
serotyp
group
two
speci
hrva
hrvb
recent
defin
third
speci
contain
genotyp
identifi
character
entir
molecular
mean
cousin
four
enteroviru
speci
eva
evb
evc
evd
also
found
airway
time
systemat
mechanist
studi
hrv
etiolog
pathogenesi
inform
studi
adult
mostli
prior
discoveri
hrvc
adult
exhibit
reduc
symptom
hrv
infect
prior
exposur
result
protect
immun
memori
impart
see
sect
furthermor
mani
modern
studi
draw
conclus
lower
respiratori
tract
lrt
diseas
use
urt
specimen
infrequ
sampl
across
small
cross
section
time
limit
hamper
attempt
associ
viru
detect
diseas
current
think
hrvc
may
key
player
asthma
exacerb
although
inabl
cultur
routin
hinder
progress
understand
role
impact
hrv
underestim
decad
concept
hrv
larg
assemblag
genet
immunogen
antigen
tempor
distinct
stabl
viral
entiti
remain
rare
commonli
consid
singl
variabl
viru
view
scienc
support
diseas
commonli
associ
airway
result
hrv
infect
common
cold
selflimit
coryz
ill
term
date
back
ancient
greec
evid
syndrom
asthma
anoth
diseas
frequent
due
hrv
infect
us
sinc
ancient
time
view
write
eber
papyru
medic
document
written
sixteenth
centuri
bc
common
cold
consid
either
due
exposur
element
infect
bacteria
later
understood
larg
due
someth
bacteriafre
filtrat
search
viral
caus
began
common
cold
unit
ccu
establish
salisburi
uk
seek
solut
mysteri
common
cold
mostli
adult
volunt
infect
studi
care
systemat
scienc
ccu
function
year
first
vitro
cultur
hrv
achiev
use
lung
tissu
particular
embryo
fig
propag
fail
tissu
expend
hrv
isol
possibl
viral
serotyp
develop
cultur
techniqu
refin
lead
intern
effort
character
name
hrv
renew
interest
hrv
research
trigger
descript
distinct
clade
hrv
type
found
use
molecular
type
result
flurri
hrv
research
rais
question
mani
earlier
paradigm
rhinovirolog
role
establish
respiratori
virus
ari
novel
clade
propos
new
speci
hrvc
taxonom
confirm
prior
discoveri
hrvc
genu
rhinoviru
abolish
hrva
hrvb
speci
assign
genu
enteroviru
within
famili
picornavirida
hrvc
assign
new
name
scheme
base
genet
sequenc
absenc
antigen
serolog
data
sequenc
serotyp
hrv
genom
complet
hrvc
appar
novel
hrva
hrvb
similarli
character
full
spectrum
hrv
genom
rhinovirom
remain
incomplet
chapter
describ
individu
serotyp
hrv
classic
type
type
descript
singl
genet
stabl
standalon
hrv
origin
clinic
definit
hrv
infect
written
use
data
cell
tissu
cultur
adult
human
infect
studi
vitro
isol
method
employ
viru
interfer
test
easili
determin
success
isol
cultur
suspect
infect
uncharacter
hrv
prevent
infect
anoth
readili
titrat
viru
later
price
jh
strain
pelon
cowork
strain
develop
cultur
system
permit
hrv
replic
easili
identifi
earli
hrv
initi
classifi
echovirus
echo
later
time
propag
hgp
strain
result
use
increas
acid
lower
cultiv
temperatur
constant
motion
rotat
despit
challeng
viru
isol
sensit
indic
infect
antibodi
rise
pair
sera
found
sever
cell
line
method
requir
encompass
viru
concentr
rang
growth
differ
among
differ
viru
type
addit
cell
age
plate
h
inoculum
volum
relev
cultur
vessel
medium
ph
cell
densiti
import
factor
reproduc
appear
hrvinduc
plaqu
higher
viru
yield
hrv
grow
temperatur
prefer
certain
condit
roll
preced
stationari
incub
period
histor
provid
highest
yield
fastest
vitro
hrv
growth
serodiagnosi
grew
increasingli
impract
number
serotyp
increas
howev
antibodybas
method
essenti
typespecif
neutral
infect
earli
epidemiolog
data
deriv
around
hrv
nomenclatur
system
evolv
first
classic
strain
offici
name
last
today
know
cell
culturebas
method
unreli
accur
repres
respiratori
viru
epidemiolog
although
enhanc
immunofluoresc
still
use
hrvc
success
cultur
cell
line
primari
cell
cultur
although
mani
attempt
describ
anoth
hrvc
shown
grow
use
organ
cultur
sinu
tissu
host
increas
level
viral
rna
adenoid
tonsil
nasal
polyp
tissu
much
less
effect
measur
situ
hybrid
sinu
organ
cultur
system
also
allow
test
first
revers
engin
hrvc
isol
identifi
hrv
adult
ari
associ
ill
per
year
cultur
ineffici
subject
requir
expertis
even
cultur
hrv
type
becom
art
lost
clinic
laboratori
world
unsurpris
pcrbase
method
prevail
provid
much
improv
understand
natur
scope
hrv
infect
virolog
immunobiolog
cost
improv
pauciti
low
passag
wild
hrv
isol
work
thu
mani
research
find
recent
year
employ
easi
grow
highli
passag
adapt
hrv
isol
impact
viru
adapt
reliabl
data
use
virus
unknown
pcrbase
assay
dramat
increas
frequenc
hrv
detect
improv
sensit
reduc
turnaround
time
shown
hrv
group
usual
predomin
virus
ari
case
reliabl
detect
level
extend
well
clinic
relev
load
pcr
detect
viru
level
commonli
shed
stage
experiment
infect
studi
common
understand
system
symptomat
context
hrv
detect
establish
era
cultur
detect
pcr
challeng
paradigm
detect
viru
often
cultur
hrv
sometim
found
healthi
control
howev
like
thought
definit
healthi
detect
would
reduc
uncommon
experi
feel
one
come
someth
never
develop
like
due
transient
infect
reinfect
hrv
respiratori
viru
elimin
quickli
host
respons
possibl
correl
viral
nucleic
acid
load
sampl
site
diseas
sever
howev
made
difficult
highli
variabl
sampl
effici
respiratori
tract
specimen
permit
gener
reliabl
quantit
pcr
qpcr
data
serial
specimen
avail
untransl
region
utr
fig
common
target
diagnost
oligonucleotid
sinc
first
hrv
rtpcr
region
retain
relev
viru
detect
adapt
revers
transcriptas
realtim
method
rtrtpcr
compris
number
conserv
sequenc
island
fig
permit
robust
detect
major
hrv
respiratori
ev
regularli
detect
respiratori
tract
detect
respiratori
ev
way
detract
import
support
clinic
decis
make
use
assay
howev
reposit
primer
chang
method
employ
may
undermin
assay
perform
evidenc
predict
hybrid
mismatch
uncommonli
low
detect
frequenc
comparison
multipl
primer
set
use
specimen
addit
oligoprob
rtpcr
method
increas
amplicon
detect
sensit
specif
identifi
fewer
fold
fewer
genom
copi
agaros
gel
detect
amplicon
molecular
tool
capabl
detect
multipl
target
evolv
recent
year
gone
approv
clinic
laboratori
use
microarray
detect
thousand
viral
target
expens
routin
use
per
sampl
sensit
enough
avoid
prehybrid
pcr
amplif
use
clinic
specimen
robust
microarray
like
pcr
reli
exist
conserv
region
sequenc
detect
unknown
virus
allow
detect
previous
unknown
hrv
type
highthroughput
deep
sequenc
platform
becom
less
expens
readili
avail
succeed
find
new
divers
within
hrv
speci
experi
remain
costli
yet
found
place
regular
screen
task
remain
coupl
need
prepcr
step
rapid
protein
virionbas
assay
yet
adequ
sensit
high
number
hrv
high
frequenc
infect
genotyp
method
becom
essenti
accompani
understand
hrv
epidemiolog
nucleotid
sequenc
call
hereaft
region
replac
tradit
serolog
method
speed
need
fewer
special
reagent
compar
serotyp
yield
comprehens
subgenom
genotyp
inform
essenti
minim
definit
new
hrv
type
region
fig
consid
easier
use
encompass
suffici
genet
divers
confirm
ident
clinic
hrv
type
also
provid
broad
enough
sensit
amplifi
hrv
challeng
biolog
substrat
clinic
specimen
screen
airway
specimen
hrv
routin
due
factor
includ
cost
perceiv
low
clinic
relev
detect
genotyp
mostli
releg
research
facil
hrv
molecular
epidemiolog
studi
tend
smaller
focus
specif
diseas
research
question
virion
encapsul
approxim
kb
posit
sens
rna
genom
fig
tend
adenin
uracil
au
rich
ev
genom
particular
au
frequent
occupi
third
wobbl
codon
posit
singl
rna
gene
act
messeng
rna
encod
singl
multidomain
proteolyt
process
polyprotein
code
region
bracket
utr
perform
regulatori
function
necessari
genom
duplic
similar
genom
transcript
translat
featur
close
cousin
ev
inform
current
requir
viru
identif
intern
committe
taxonomi
virus
ictv
found
analysi
genet
featur
hrv
fig
complet
hrv
polyprotein
genbank
databas
fig
first
complet
hrv
genom
sequenc
describ
follow
fig
kistler
et
al
ad
genom
tapparel
et
al
includ
one
common
studi
sequenc
region
complet
classic
strain
complet
set
region
avail
current
least
name
hrvc
region
avail
complet
hrvc
genom
mani
genom
appear
part
rhinoviru
consortium
effort
complet
studi
rhinovirom
use
highthroughput
sequenc
technolog
genet
character
hrv
combin
clinic
specimen
store
http
wwwinternationalrhinovirusconsortiumorg
mani
sequenc
resid
genbank
databas
label
use
inhous
laboratori
scheme
rather
approv
nomenclatur
analysi
fulllength
genom
support
use
subgenom
region
use
represent
hrv
speci
type
recombin
process
genet
exchang
result
chimer
genom
detect
matur
virus
fact
must
therefor
infer
indirectli
genom
analysi
comparison
predict
infrequ
recombin
among
hrv
made
base
examin
avail
set
hrv
code
noncod
region
intens
analys
report
recombin
drive
forc
evolut
hrv
type
discrep
like
differ
number
sequenc
use
differ
origin
virus
use
sequenc
analysi
method
employ
hrvc
evolut
seem
affect
prior
recombin
appar
member
hrva
hrvb
similar
ev
speci
far
fewer
predict
recombin
event
ev
evolut
recombin
propos
affect
hrv
occur
hrvc
hrva
often
found
within
junction
rare
code
sequenc
high
sequenc
divers
among
individu
hrv
polyprotein
code
sequenc
may
keep
recombin
event
minimum
order
retain
viral
fit
abil
hrv
recombin
practic
await
empir
evid
extent
recombin
among
hrv
ev
type
frequenc
viabl
recombin
aris
entir
unquantifi
nm
hrv
virion
visual
hand
hrva
hrvb
type
includ
hrvc
structur
empir
determin
date
first
describ
follow
hrvc
structur
predict
use
comput
model
basic
structur
seem
expect
hrv
fig
hrv
capsid
shell
compos
protom
compris
one
copi
viral
protein
kda
extent
expos
capsid
surfac
wherea
kda
intern
associ
viral
rna
five
protom
come
togeth
point
around
fivefold
axi
cluster
call
pentam
fivefold
axi
circumscrib
cleft
refer
canyon
form
convolut
set
protein
sheet
loop
loop
protrud
beyond
extern
capsid
surfac
contain
discontinu
antigen
site
hrv
type
studi
four
neutral
antibodi
immunogen
nim
region
identifi
locat
nimii
nimiii
antigen
site
identifi
call
b
c
scope
locat
antigen
immunogen
moieti
among
hrvc
unknown
use
known
receptor
bind
sequenc
guid
comput
model
fig
predict
discov
receptor
hrvc
differ
major
minor
receptor
defin
hrva
hrvb
three
hrv
speci
within
genu
enteroviru
genet
immunogen
antigen
divers
assemblag
viral
type
tabl
account
combin
exclus
actual
despit
confus
acid
liabil
combin
hrvhank
actual
serolog
studi
indic
hrva
hrvb
type
may
distinct
enough
deserv
uniqu
ident
speci
within
genu
share
amino
acid
aa
ident
polyprotein
aa
ident
fig
well
host
cell
receptor
limit
natur
host
rang
genom
base
composit
gc
vari
similar
compat
proteolyt
process
replic
encapsid
genet
recombin
variant
hrv
type
share
aa
ident
much
nongenet
criteria
remain
undefin
hrvc
genera
enteroviru
rhinoviru
offici
combin
retain
former
genu
name
enteroviru
human
enteroviru
c
prototyp
speci
genu
order
picornaviral
famili
picornavirida
least
differ
amino
acid
ident
genu
propos
establish
speci
human
rhinoviru
c
ratifi
ictv
formal
hrvc
number
commenc
type
number
initi
assign
base
date
submiss
relev
sequenc
genbank
formerli
f
f
qpm
f
etc
tabl
clinic
detect
hrvc
consid
novel
type
princip
base
sequenc
provision
cpat
tabl
base
could
confirm
variant
previous
character
hrvc
ident
threshold
either
region
still
use
hrv
genotyp
problemat
region
recombin
activ
affect
region
especi
among
hrvc
present
phylogenet
intermingl
hrva
hrvc
type
nonetheless
care
applic
sequenc
ident
threshold
compar
clinic
sequenc
genbank
databas
ident
requir
assign
clinic
detect
particular
type
succe
character
hrv
speci
type
current
type
within
hrvc
includ
type
group
togeth
hrv
hrvx
hrvni
clade
hrva
type
hrvb
uptod
inform
current
taxonom
trend
found
ictv
picornavirida
studi
group
websit
http
wwwpicornastudygroupcom
histor
key
featur
distinguish
hrv
ev
instabl
hrv
capsid
presenc
acid
lower
prefer
laboratori
propag
temperatur
versu
ev
time
hrv
subclassifi
differ
way
first
base
tissu
tropism
host
rang
hrv
prefer
growth
use
monkey
cell
call
strain
major
grew
human
cell
cultur
h
strain
two
group
correl
receptor
usag
tabl
possibl
titer
inoculum
employ
propos
abandon
terminolog
favor
sequenti
number
system
picornavirus
recogn
varieti
cellular
receptor
hrv
type
also
subdivid
major
minor
group
defin
use
one
two
main
receptor
molecul
capsid
major
classic
hrv
n
interact
aminotermin
domain
kda
intercellular
adhes
molecul
receptor
bind
destabil
hrv
capsid
probabl
dislodg
pocket
factor
initi
uncoat
interact
receptor
leukocyt
function
play
role
recruit
migrat
immun
effector
cell
minor
group
classic
virus
employ
member
lowdens
lipoprotein
receptor
ldlr
famili
attach
cell
bind
vldlr
occur
outsid
canyon
employ
differ
destabil
uncoat
mechan
heparan
sulfat
may
act
receptor
specif
condit
andri
et
al
defin
lain
et
al
refin
two
antivir
group
b
base
suscept
panel
antivir
molecul
group
reflect
natur
amino
acid
henc
nucleotid
sequenc
region
interact
antivir
molecul
antivir
group
also
visual
use
phylogeni
sequenc
subgenom
region
includ
examin
phylogeni
speci
found
case
invers
correl
antivir
group
label
tabl
today
sequenc
phylogeni
play
central
role
speci
classif
within
genu
togeth
surrog
import
biolog
classif
criteria
hrvc
first
describ
clade
confus
singl
viru
name
scheme
appear
hrvc
clade
name
propos
virus
sequenc
provid
bulk
hrv
inform
clinic
studi
cultur
primari
sinu
tissu
report
receptor
yet
defin
studi
rel
sensit
nasopharyng
aspir
npa
swab
sampl
method
produc
differ
result
gener
seek
best
diagnost
yield
mani
respiratori
virus
possibl
ie
seek
laboratori
diagnosi
support
clinic
decis
make
npa
sampl
optim
choic
one
studi
report
similar
clinic
sensit
swab
npa
human
coronavirus
hcov
ifv
hrsv
reduc
sensit
use
swab
hrv
human
adenovirus
hadv
human
metapneumoviru
hmpv
parainfluenza
virus
hpiv
second
studi
report
differ
sensit
hrv
hadv
hpiv
reduc
sensit
hrsv
ifv
use
swab
nasopharyng
wash
also
yield
viral
cultur
success
either
nasal
pharyng
swab
nonetheless
mani
studi
use
nasal
swab
sampl
choic
allow
selfcollect
involv
much
less
discomfort
npa
pcr
meant
infecti
viru
requir
viral
nucleic
acid
relax
limit
impos
need
rapid
care
temperaturecontrol
expens
transport
requir
bronchoalveolar
lavag
sampl
best
seek
lrt
etiolog
especi
adult
nasal
wash
viral
load
low
compar
children
invas
method
risk
attach
hrv
infect
peopl
around
globe
spread
hrv
obviou
frequent
child
child
child
parent
popul
mix
age
major
hrv
detect
occur
children
among
specimen
healthi
children
third
hrv
posit
children
less
year
age
hrv
posit
shown
hrv
infect
wider
divers
hrv
type
children
year
old
hrv
posit
healthi
adult
militari
univers
home
workplac
also
featur
promin
histor
culturebas
volunt
infect
studi
heavili
influenc
view
hrv
infect
outcom
although
studi
children
hospitalbas
popul
usual
report
signific
clinic
outcom
relat
lrt
communitybas
studi
data
still
broadli
applic
hospit
popul
origin
commun
reflect
seriou
perhap
first
exposur
viru
hospitalbas
popul
defin
potenti
viru
caus
sever
clinic
outcom
diseas
end
spectrum
strongest
influenc
futur
priorit
therapeut
research
develop
modern
air
travel
contribut
rapid
spread
respiratori
virus
seen
often
frequent
detect
among
travel
includ
febril
ill
apart
children
hrv
found
great
clinic
impact
elderli
describ
year
age
ari
posit
hrv
sometim
greater
burden
diseas
ifv
asthma
copd
also
affect
ari
trigger
exacerb
wheez
ill
see
sect
thought
differ
type
infect
rather
differ
respons
infect
host
wheez
also
result
infect
atop
peopl
underli
asthma
copd
hrv
caus
signific
impact
immunocompromis
group
popul
date
found
host
truli
persist
hrv
infect
see
sect
hrv
largest
group
virus
infect
human
surpris
confus
differenti
diagnos
pandem
key
role
codetect
asymptomat
diseas
studi
hrv
studi
respiratori
virus
consid
isol
like
detriment
greater
understand
respiratori
viru
pathogenesi
hrv
circul
throughout
year
usual
bimod
peak
temper
locat
hemispher
highest
peak
mostli
defin
use
adult
popul
autumn
fall
spring
peculiarli
monday
major
winter
dip
hrv
preval
close
coincid
peak
respiratori
virus
particularli
ifv
hrsv
one
hypothesi
state
miasma
exist
school
classroom
particular
relev
suffer
asthma
exacerb
miasma
maintain
immun
stimul
subsequ
wane
among
school
children
holiday
challeng
anew
upon
return
school
clear
interplay
interfer
take
place
virus
popul
level
particularli
evid
among
rna
virus
correl
spike
spring
autumn
hrv
case
number
asthma
exacerb
season
day
return
school
holiday
rang
climat
particularli
obviou
among
asthma
hospit
children
year
age
ontario
canada
peak
week
across
decad
upon
investig
hrv
preval
virus
found
analysi
emerg
room
present
ontario
hrv
also
predomin
hay
fever
season
although
defin
season
alway
found
tropic
may
sometim
due
test
includ
hrv
hrv
hrv
type
continu
circul
today
includ
name
earliest
nomenclatur
assign
singl
site
month
type
cocircul
drop
studi
time
frame
site
shorten
recur
hrv
type
defin
use
molecular
tool
account
viru
detect
birth
cohort
follow
month
anoth
cohort
occur
twice
two
children
within
period
within
given
year
across
differ
year
appar
hrv
speci
exchang
predomin
evid
exist
satisfactorili
explain
howev
herd
immun
may
factor
use
cell
tissu
cultur
underestim
frequenc
multipl
infect
patient
like
domin
viru
outrepl
other
due
viral
load
differ
specimen
qualiti
issu
differ
cell
tropism
trigger
antivir
state
first
viru
major
respiratori
virus
sought
use
pcr
techniqu
multipl
virusposit
specimen
compris
third
test
drop
around
fifth
ari
episod
fewer
virus
sought
sometim
emphasi
high
number
hrv
case
identifi
presenc
anoth
viru
includ
hrv
test
rais
frequenc
pathogen
detect
one
per
sampl
coinfect
correctli
pcrbase
studi
codetect
sinc
pcr
determin
infect
found
either
increas
impact
clinic
outcom
host
issu
clinic
relev
codetect
still
uncertain
extrem
case
half
hrv
detect
found
concurr
anoth
viru
surfac
signific
fraction
yet
hrsv
hmpv
ev
ifv
detect
detect
found
compani
anoth
viru
studi
find
differ
still
higher
proport
codetect
involv
nonhrv
whether
codetect
repres
particular
synerg
involv
virus
differenti
capabl
manipul
host
immun
respons
sign
innocu
frequent
involv
viru
chanc
due
overlap
season
remain
unclear
clear
howev
codetect
anomali
error
due
overli
sensit
pcr
test
evid
biolog
complex
recent
remain
hidden
us
recent
studi
shown
initi
impress
hrv
overrepres
case
incorrect
closer
analysi
viral
codetect
reveal
pattern
becam
clear
codetect
examin
bidirect
mani
hrv
posit
viru
x
also
mani
viru
x
case
posit
hrv
whether
hospit
commun
set
hrv
often
occur
sole
viru
detect
ari
consid
ubiqu
interest
rel
low
number
concurr
detect
occur
support
concept
hrv
direct
role
clinic
outcom
infect
hrv
partnership
host
immun
may
mutualist
one
inadvert
impart
advantag
host
protect
cytopath
respiratori
viral
pathogen
host
provid
vessel
hrv
replic
transmiss
studi
singl
respiratori
virus
without
context
respiratori
virom
limit
valu
draw
conclus
clinic
impact
much
longitudin
epidemiolog
data
previous
reli
upon
form
assess
hrv
signific
acquir
use
culturebas
techniqu
improv
comprehens
test
pattern
seen
among
interact
hrv
respiratori
virus
viru
interfer
type
virusviru
interact
vvi
known
decad
vvi
recent
categor
type
popul
level
note
trial
live
attenu
ifv
laiv
vaccin
interferon
ifn
respons
trigger
protect
vaccine
offtarget
virus
day
postvaccin
studi
went
far
suggest
effect
could
maintain
prolong
period
use
regim
consecut
schedul
vaccin
separ
day
time
prolong
epidem
similar
effect
produc
use
live
ev
vaccin
lev
replac
pathogen
ev
type
interrupt
outbreak
oral
administ
lev
succeed
princip
task
also
reduc
incid
ari
epidem
overal
show
immun
activ
gastrointestin
system
gener
anatom
distinct
protect
effect
may
similar
effect
gut
inflammatori
statu
respiratori
viru
infect
contrast
laiv
result
offtarget
protect
effect
revers
studi
use
trival
inactiv
ifv
vaccin
mechan
underneath
oppos
outcom
unclear
heyday
tissu
cultur
viru
studi
common
biolog
assay
infect
hrv
involv
attempt
infect
cultur
enteroviru
ev
failur
superinfect
viru
grow
herald
like
presenc
noncytopathogen
hrv
viru
interfer
use
measur
ifn
specimen
inhibit
hrv
growth
recent
hrvhadv
dual
pcrposit
case
found
less
often
expect
harbor
lower
viral
load
hrv
specimen
case
sole
hrv
infect
significantli
major
instanc
vvi
involv
rna
virus
shown
dual
infect
peripher
blood
mononuclear
cell
pbmc
virus
hrsv
includ
hrv
induc
immun
respons
similar
singl
infect
coinfect
includ
hrsv
result
reduc
respons
vvi
affect
abil
moder
host
respons
viru
interfer
also
identifi
viru
posit
seri
pattern
among
respiratori
specimen
test
respiratori
virus
fig
statist
analys
support
mani
codetect
occur
pattern
particular
fewer
codetect
involv
hrv
would
expect
chanc
alon
p
period
rna
viru
infect
especi
hrv
group
may
render
host
less
like
infect
virus
extrapol
commun
level
help
constrict
epidem
period
virus
reduc
number
fulli
suscept
host
viru
interfer
featur
respiratori
viru
epidemiolog
also
seen
result
studi
period
span
peak
pandem
influenza
season
wisconsin
influenza
viru
ifav
seem
domin
hrv
children
asthma
sampl
weekli
whether
reflect
ifvhrv
interact
involv
novel
ifv
unclear
found
pbmc
children
exhibit
normal
immun
respons
report
subject
continu
extend
greater
week
period
hrv
posit
increas
pcr
method
replac
cell
cultur
hrv
detect
rare
record
use
cultur
hrv
rna
detect
day
prior
symptom
commenc
long
week
ceas
studi
defin
period
ari
children
time
specimen
rtpcr
neg
detect
overlap
serial
infect
fig
epidemiolog
incorpor
hrv
type
gener
find
chronic
shed
hrv
shed
normal
ceas
within
day
sign
symptom
stop
thu
percept
persist
probabl
due
serial
overlap
infect
multipl
untyp
strain
studi
suitabl
address
persist
hrv
infect
involv
healthi
subject
sinc
pre
postsampl
clinic
data
rare
describ
date
true
ongo
detect
singl
confirm
hrv
limit
individu
underli
immunosuppress
immun
dysfunct
hrvc
detect
three
time
longer
immunocompromis
young
patient
immunocompet
children
mean
versu
day
multipl
detect
hrv
type
ident
sequenc
patient
time
extend
month
hematopoiet
stem
cell
transplant
recipi
proof
causal
difficult
achiev
proof
innocu
come
respiratori
virus
ari
definit
well
subject
prior
time
sampl
inocul
sometim
clear
especi
young
children
reliabl
report
symptom
often
parent
notic
symptomat
ill
infect
detect
laboratori
support
import
diari
longitudin
homebas
commun
studi
nonetheless
even
support
telephon
interview
home
visit
milder
cold
symptom
may
miss
uncommon
asymptomat
control
subsequ
becom
symptomat
symptomat
sampl
studi
employ
sensit
symptom
score
system
criteria
symptomat
usual
design
describ
clearli
discrimin
overt
sever
ill
obviou
measur
sign
strict
definit
help
improv
patient
manag
commenc
better
direct
treatment
cohort
howev
research
studi
arbitrari
degre
sever
requir
report
symptomat
event
often
overlook
simpl
chang
host
biolog
due
viru
replic
chang
norm
mild
nonetheless
repres
diseas
disord
structur
function
produc
specif
symptom
affect
specif
locat
simpli
direct
result
physic
injuri
liter
sens
minor
shortliv
often
unrecord
indic
infect
includ
sinu
pain
headach
sore
throat
earach
wateri
eye
fatigu
muscl
ach
pain
mood
chang
within
famili
hrv
frequent
transmit
children
usual
symptomat
infant
frequent
expos
children
asymptomat
viral
infect
among
infect
adult
famili
member
asymptomat
infect
like
among
older
parent
whether
children
live
home
asymptomat
infect
frequent
follow
hrv
challeng
among
adult
without
children
younger
parent
studi
viral
speci
agestratifi
case
control
significantli
lower
viral
load
found
without
requir
symptom
qpcr
may
prove
use
determin
viral
load
cutoff
address
issu
futur
although
respiratori
tract
difficult
tissu
qpcr
high
sensit
pcrbase
method
rais
concern
clinic
relev
virusposit
result
clear
proport
around
five
studydefin
asymptomat
control
popul
viru
posit
use
sensit
pcrbase
method
may
vari
nearli
case
stratifi
age
viru
season
includ
highrisk
popul
everi
respiratori
viru
even
ifv
hrsv
found
case
without
symptom
time
specimen
collect
even
specif
inocul
adult
complex
incomplet
stori
need
research
frustrat
posit
asymptomat
peopl
often
use
rank
viral
import
better
data
requir
asymptomat
control
conclus
drawn
causal
requir
often
disregard
memori
normal
function
protect
host
immun
host
respons
defin
degre
clinic
sever
inflammatori
diseas
hallmark
ari
well
known
previou
exposur
viru
afford
protect
full
clinic
spectrum
diseas
upon
repeat
exposur
viru
come
surpris
hrv
usual
caus
brief
infect
anyway
could
well
produc
minor
sign
symptom
upon
reinfect
uniqu
extrem
person
infect
histori
member
control
group
determin
unless
part
longitudin
cohort
cohort
studi
support
comprehens
pcrbase
test
tell
us
asymptomat
viru
infect
cohort
studi
look
asymptomat
children
seek
sampl
time
symptomat
ill
birth
cohort
children
enrol
sampl
ill
everi
month
month
identifi
hrv
infant
toddler
nasal
symptom
defin
sole
presenc
rhinorrhea
childhood
origin
asthma
coast
birth
cohort
follow
infant
high
risk
allergi
asthma
month
identifi
hrv
infect
preced
mean
age
first
detect
month
hrsv
mean
age
least
month
hrv
found
asymptomat
versu
moder
sever
ill
patient
frequent
symptomat
children
also
greatest
proport
asymptomat
infect
studi
children
asthma
sampl
weekli
week
two
peak
hrv
season
nearli
twothird
viru
posit
sensit
least
one
allergen
show
asthma
symptom
nearli
half
show
ari
symptom
children
sensit
less
onethird
show
asthma
symptom
fifth
ari
symptom
conveni
popul
healthi
children
year
old
without
asthma
follow
least
three
season
picornavirus
detect
specimen
infect
associ
symptom
although
infect
came
household
infect
sibl
summari
clear
evid
presenc
hrv
asymptomat
control
precis
proport
yet
defin
studi
control
show
sign
leadin
period
rna
posit
preced
ari
defin
followup
other
may
defin
symptomat
symptom
account
hrv
found
extrarespiratori
site
viremia
determin
blood
children
lrt
infect
pericard
hrvc
commonli
associ
viremia
hrva
support
possibl
increas
pathogen
blood
also
posit
hrv
rna
infecti
viru
infant
necropsi
hrv
rna
detect
plasma
children
asthma
bronchiol
common
cold
hrv
isol
fece
recent
higher
expect
load
hrv
detect
fecal
specimen
children
suspect
mening
fever
unknown
origin
gastroenter
child
pericard
nonetheless
nasopharynx
still
consid
main
site
focal
viru
product
regardless
inocul
rout
studi
transmiss
rout
center
urt
contrast
ifv
hrsv
hrv
infect
involv
less
destruct
tissu
ciliat
epitheli
cell
slough
proport
sever
hrv
ari
damag
minim
occur
viral
incub
period
subclin
infect
incub
period
infect
onset
viru
shed
nasal
secret
day
shed
viral
titer
peak
adult
day
time
success
hrv
transmiss
among
adult
childless
famili
set
usual
day
requir
donor
shed
least
stage
recover
viru
hand
nare
enough
share
time
moder
sever
ari
lung
shown
host
replic
hrv
reader
report
may
left
percept
detect
hrv
replic
lrt
explain
lrt
symptom
howev
rel
studi
seek
identifi
true
hrv
replic
lrt
overwhelm
major
lrt
case
detect
hrv
urt
correl
urt
posit
lrt
diseas
exist
well
known
experiment
inocul
studi
hrv
infect
result
inocul
conjunctiv
sac
viru
move
nasolacrim
duct
studi
viru
commonli
deliv
aerosol
intranas
instil
ml
ml
suspens
laboratori
hrv
retain
infect
hour
day
suitabl
nonpor
solid
surfac
especi
inoculum
remain
damp
support
direct
selfinocul
especi
famili
set
indirect
inocul
via
fomit
trial
defin
movement
viru
contamin
donor
recipi
via
multipl
surfac
handtohand
contact
donor
object
recipi
donor
recipi
finger
viru
recover
donor
fingertip
recover
recipi
even
observ
eye
rub
nosepick
occur
frequent
suggest
selfinocul
could
outpac
person
hygien
particularli
young
thought
strang
ari
common
isol
rate
expect
virus
low
better
understand
import
preexist
antibodi
someth
common
among
predominantli
adult
volunt
use
mani
studi
discoveri
third
uncultur
speci
hrv
still
caus
ari
imposs
isol
detect
use
antibodybas
system
reagent
exist
vastli
improv
diagnost
sensit
much
less
confound
past
household
cross
infect
determin
ari
low
five
exposur
infect
member
requir
infect
despit
viral
load
nasal
wash
peak
experiment
transmiss
also
reportedli
ineffici
contrast
natur
closequart
militari
popul
interact
week
experienc
rapid
spread
hrv
group
use
pcr
recent
clarifi
discrep
confirm
frequent
transmiss
famili
common
culturebas
studi
identifi
often
result
asymptomat
infect
among
older
sibl
parent
pcr
help
defin
scope
viral
rna
actual
infecti
viru
surviv
spread
transmiss
studi
requir
infecti
hrv
hrvc
contribut
histor
data
crowd
intim
condit
sever
cold
transmiss
reach
studi
larg
smallparticl
aerosol
prove
ineffici
support
low
isol
rate
saliva
compar
hand
wash
nasal
swab
particip
expos
largeparticl
aerosol
human
donorrecipi
model
studi
howev
aerosol
prove
main
transmiss
rout
among
antibodyfre
adult
discrep
may
due
insuffici
long
intens
exposur
earlier
aerosol
experi
apart
particl
size
spread
viru
aerosol
affect
exist
nasal
obstruct
divert
secret
nare
contamin
saliva
presumpt
sourc
viru
cough
sneez
expos
liter
smallparticl
aerosol
associ
fever
promin
tracheobronch
antibodyfre
adult
volunt
deliv
via
nasal
drop
coars
aerosol
also
found
simpl
breath
releas
hrv
rna
type
also
identifi
nasal
mucou
least
third
adult
children
symptomat
ari
infecti
hrv
could
isol
fifth
appar
hrv
accumul
site
heavi
human
traffic
potenti
form
secondari
sourc
infect
hrv
rna
detect
filter
place
sampl
air
offic
build
aircraft
high
effici
particul
air
hepa
filter
found
harbor
hrv
rna
day
remov
servic
virusreceptor
bind
intern
earliest
host
cell
immun
respons
hrv
infect
elicit
innat
immun
system
fig
epitheli
cell
repres
front
line
hrv
invas
although
alveolar
macrophag
dc
better
equip
respond
despit
host
hrv
replic
directli
viru
detect
mediat
pattern
recognit
receptor
prr
evolv
recogn
conserv
molecular
structur
share
among
divers
pathogen
intern
surfacemount
prr
includ
sentinel
specif
recogn
picornaviru
rna
protein
trigger
immun
circuit
result
product
ifn
subsequ
hundr
ifnstimul
gene
product
innat
respons
viral
infect
hing
induc
two
type
ifn
initi
secret
cytokin
produc
antivir
antiprolif
immunomodulatori
outcom
type
iii
ifn
also
produc
respons
viral
infect
rang
cell
although
receptor
widespread
type
ii
ifn
produc
activ
cell
natur
killer
cell
rather
direct
respons
viru
detect
viral
compon
trigger
protein
signal
cascad
regul
ifn
synthesi
activ
viral
stressinduc
gene
vsig
sometim
express
constitut
upregul
ifn
induct
follow
hrv
infect
releas
bind
receptor
autocrin
cell
paracrin
neighbor
cell
manner
start
posit
feedback
loop
type
ifn
product
second
wave
vsig
includ
antivir
protein
protein
kinas
r
pkr
mx
protein
upregul
express
mxa
pkr
mx
pathway
also
induc
viru
infect
constitut
express
depend
sentinel
system
stimul
differ
pathway
vsig
activ
vsig
antivir
properti
eg
mxa
pkr
inhibit
differ
stage
viru
replic
strengthen
antivir
state
host
state
well
known
natur
induct
differ
respiratori
virus
impact
induct
upon
replic
respiratori
virus
topic
consider
ongo
research
one
pathway
ifn
induct
reli
ifnupregul
cytosol
sentinel
retino
acid
induc
gene
rigilik
receptor
rlr
rigi
specif
ifav
other
melanoma
differentiationassoci
gene
specif
picornavirus
other
rna
helicas
recogn
either
rna
distinct
dsrna
result
activ
lead
classic
type
ifn
induct
studi
innat
respons
hrv
infect
limit
use
easili
cultur
type
presum
result
extrapol
type
yet
test
rigi
degrad
ifn
regulatori
factor
irf
homodimer
interf
limit
induct
degrad
anoth
pathway
recogn
hrv
infect
involv
tolllik
receptor
tlr
transmembran
prr
termin
intracellular
signal
region
endosom
local
recogn
nucleic
acid
also
involv
innat
antivir
respons
identifi
gurich
ssrna
endocytos
virus
recogn
unmethyl
cpg
dna
present
dna
virus
found
cell
surfac
recogn
hrv
hrsv
protein
respect
recogn
dsrna
tlr
oper
mainli
exclus
plasmacytoid
dc
particular
tlr
notifi
hrv
incurs
may
depend
method
viru
approach
activ
reduc
mxa
mrna
express
protein
adolesc
asthma
compar
healthi
control
activ
result
similar
dispar
suggest
hrv
may
evolv
human
extent
symbiot
relationship
serv
help
train
human
immun
system
intriguingli
within
hrv
speci
differ
type
level
host
respons
induc
may
reflect
receptor
usag
rout
entri
cell
type
infect
hrv
speci
degre
laboratoryadapt
viru
use
vitro
studi
initi
hrv
infect
innat
respons
result
product
proinflammatori
cytokin
vasoact
peptid
chemokin
attract
leukocyt
granulocyt
dc
monocyt
tabl
tlymphocyt
respons
viral
intrus
broadli
categor
tcell
subset
exist
work
relat
hrv
conduct
earliest
defin
subset
cellular
respons
import
manag
cellular
immun
produc
interleukin
il
cellular
respons
manag
humor
immun
stimul
b
cell
via
initi
product
ige
influenc
eosinophil
crucial
compon
allergeninduc
asthma
two
tcell
respons
act
concert
epithelialderiv
chemokin
eg
eotaxin
promot
recruit
activ
eosinophil
mast
cell
contribut
chronic
airway
inflamm
hyperrespons
airway
varieti
nonspecif
stimuli
lymphocyt
oppos
lymphocyt
contribut
allerg
inflammatori
cascad
akin
occur
rid
human
parasit
respons
also
repress
bind
microrna
lead
alter
balanc
favor
state
mice
probabl
human
regulatori
cell
treg
suppress
allerg
inflammatori
pathway
therefor
fundament
protect
airway
allergen
sensit
consider
immunobiolog
research
focus
asthma
exacerb
hrv
intim
involv
although
upregul
hrv
infect
respons
compar
defici
peopl
asthma
problemat
increas
cytokin
respons
deduc
higher
sputum
mrna
valu
speed
clearanc
hrv
symptom
amelior
one
possibl
caus
defici
peopl
asthma
inadequ
matur
type
iii
ifn
respons
due
reduc
exposur
infect
earli
life
hygien
hypothesi
posit
pathway
asthma
etiolog
describ
term
young
unchalleng
immun
system
depend
infect
stimul
develop
function
one
theori
suggest
hrv
play
central
role
develop
efficaci
antivir
immun
particularli
infanc
via
frequent
usual
mild
selflimit
infect
genomewid
express
analysi
bec
healthi
asthmat
adult
subject
infect
reveal
signific
differ
found
cell
type
respons
infect
includ
immun
respons
gene
airway
remodel
gene
overal
proinflammatori
respons
metabol
slowdown
consist
proteolyt
cleavag
transcript
factor
hrv
infect
cell
studi
note
similar
gene
express
chang
observ
brush
peopl
mild
asthma
allergen
exposur
bal
cell
subject
corticosteroidresist
asthma
overal
hrv
replic
host
transcript
respons
similar
normal
asthmat
bec
cell
indic
least
adult
someth
beyond
epitheli
cell
import
contributor
sever
clinic
outcom
asthma
applic
inactiv
found
promot
releas
monocyt
immunosuppress
cytokin
inhibit
stimul
drive
develop
howev
neither
significantli
induc
asthmat
adult
volunt
respons
compar
healthi
subject
detect
transfect
dc
ssrna
low
level
also
note
posit
reduc
could
indic
neg
affect
local
immun
possibl
predispos
secondari
infect
infect
stromal
lung
cell
trigger
exagger
level
pleiotrop
cytokin
akin
trigger
hrsv
also
detect
nasal
secret
children
wheez
cytokin
chang
identifi
atop
adult
volunt
challeng
gcsf
chemoattract
neutrophil
level
rose
urt
examin
protein
detect
nasal
lavag
lrt
mrna
detect
sputum
concomit
rise
blood
nasal
neutrophil
number
nasal
epitheli
cell
atop
individu
especi
season
express
nonatop
adult
normal
subject
infect
major
group
contrast
appear
later
postinfect
downregul
express
infect
cell
encourag
infiltr
neutrophil
respect
chang
level
may
modifi
tlymphocytemedi
cytotox
th
interact
hrvinfect
cell
upregul
receptor
express
encourag
eosinophil
tcell
infiltr
lower
airway
asthmat
individu
hrv
enter
cell
must
pass
defens
barrier
secret
antihrv
antibodi
mostli
iga
eas
passag
occur
proport
progress
clinic
diseas
healthi
adult
volunt
found
develop
iga
least
day
week
time
serum
retain
peak
level
least
week
fall
faster
serum
level
also
evid
degre
nasal
immun
memori
volunt
prestudi
serum
antibodi
could
still
infect
studi
other
infect
clear
volunt
without
preexist
nasal
antibodi
experiment
challeng
viru
becom
infect
exhibit
sever
ari
shed
viru
longer
iga
seem
modifi
ill
sever
viru
shed
high
level
prevent
reinfect
initi
viru
type
low
level
absenc
iga
prevent
reinfect
hrv
type
may
manifest
symptomat
asymptomat
diseas
older
children
adolesc
adult
greater
amount
hrvneutral
antibodi
young
children
accompani
trend
toward
decreas
number
symptomat
ari
increas
age
featur
rais
issu
use
older
subject
mani
common
cold
studi
underplay
pathogen
potenti
hrv
protect
partial
crossprotect
antibodi
moder
impact
infect
consequ
quantifi
level
typespecif
serum
antibodi
becam
routin
practic
prior
studi
adult
volunt
studi
determin
infect
result
preexist
neutral
antibodi
titer
exist
level
grew
level
resist
infect
adult
protect
serum
titer
trend
interrupt
adult
year
age
group
presum
begun
famili
young
children
acquir
amplifi
current
circul
type
commun
transmit
household
either
immun
lack
suffici
antibodi
cellmedi
memori
protect
tradit
vaccin
strategi
quickli
rule
prophylact
intervent
hrv
ill
extens
antigen
variabl
hallmark
genu
enteroviru
howev
possibl
identifi
master
strain
exhibit
suffici
antigen
crossreact
induc
broad
heterotyp
respons
mani
hrv
strain
effect
vaccin
could
still
possibl
fact
boost
host
immun
hrv
type
repeat
infect
heighten
immun
one
type
highest
heterotyp
antibodi
titer
develop
type
highest
preexist
antibodi
level
first
descript
unifi
hrv
number
system
recount
appear
minor
serolog
crossreact
remov
modif
techniqu
subsequ
crossreact
better
defin
experiment
inocul
multipl
hrv
immunogen
antigen
use
deduc
extent
heterotyp
respons
less
promis
hrv
vaccinolog
descript
antigen
variat
within
hrv
type
suggest
immun
one
variant
type
might
protect
infect
variant
prime
strain
specif
antigen
variant
prototyp
hrv
type
neutral
lesser
extent
antisera
prototyp
yield
antisera
effect
neutral
prototyp
anoth
form
crossneutr
ascrib
intertyp
hrv
isol
share
lowerlevel
serolog
relationship
pair
hrv
strain
share
neutral
reactiv
eg
lowlevel
reciproc
neutral
activ
equival
direct
sera
higher
titer
sera
strain
link
directli
one
twoway
crossreact
indirectli
two
strain
link
via
serum
neutral
neutral
neutral
surrog
molecular
method
provid
insight
interrelationship
perhap
expand
upon
identifi
use
pattern
vaccin
immunolog
purpos
would
welcom
summari
heterotyp
immun
hrv
intertyp
might
exploit
featur
hrv
immunobiolog
could
confer
maximum
protect
upon
host
minimum
number
hrv
type
common
cold
ill
accur
epidemiolog
burden
diseas
data
underpin
priorit
prevent
treat
research
etiolog
agent
assign
fund
research
agent
health
polici
maker
also
need
understand
efficaci
costeffect
develop
intervent
host
immun
respons
hrv
replic
main
caus
sign
quantifi
fever
rhinorrhea
symptom
feel
fever
myalgia
headach
fatigu
mood
chang
cold
host
experi
featur
common
cold
increas
vascular
permeabl
enhanc
kinin
result
increas
plasma
protein
albumin
immunoglobulin
ig
g
level
mucu
approach
level
serum
histamin
level
rise
nasal
secret
otherwis
healthi
cold
suffer
resolv
phase
ari
glandular
protein
lysozym
siga
predomin
common
cold
syndrom
also
describ
rhinosinus
agglomer
rhiniti
sinus
sinc
frequent
clinic
coexist
consist
nasal
discharg
rhinorrhea
nasal
obstruct
sore
throat
sinu
pain
headach
sneez
wateri
eye
cough
fever
fatigu
muscl
ach
pain
mood
chang
caus
directli
indirectli
viral
infect
cough
result
vagu
nerv
irrit
mucu
sneez
result
trigemin
nerv
irrit
sore
throat
like
due
action
prostaglandin
bradykinin
fever
psycholog
effect
fatigu
myalgia
mediat
cytokin
hypertroph
adenoid
also
found
high
proport
viral
especi
hrv
occup
regardless
host
symptomat
state
observ
natur
cultureconfirm
hrv
cold
adult
note
cough
usual
start
day
persist
day
later
rhinorrhea
sneez
sore
throat
report
half
patient
headach
least
quarter
case
neutrophil
accumul
site
primari
urt
infect
myeloperoxidas
azurophil
granul
creat
yellowgreen
color
nasal
mucu
consid
sign
bacteri
superinfect
common
cold
caus
hrv
clinic
distinguish
one
caus
respiratori
virus
like
singl
hrv
type
host
infect
hmpv
hpiv
ifv
etc
secondari
exposur
viru
type
produc
less
sever
clinic
outcom
due
preprim
host
immun
asthma
clinic
diagnosi
made
basi
patient
histori
physic
examin
assess
airway
obstruct
revers
respons
bronchodil
complex
chronic
respiratori
diseas
involv
airway
inflamm
airflow
obstruct
airway
hyperrespons
manifest
recurr
revers
attack
deterior
asthma
control
gener
interact
infecti
agent
environment
genet
factor
remain
incomplet
character
mechanist
role
hrv
asthma
incept
exacerb
yet
defin
reveal
extrem
complex
interplay
inflamm
due
viru
versu
due
atopi
explor
possibl
virushost
interact
includ
sever
hrv
infect
healthi
infant
may
result
subsequ
develop
asthma
ii
hrv
may
trigger
asthma
children
genet
predisposit
toward
atopi
iii
repeat
mild
infect
may
protect
asthmogeniccytopath
virus
overdevelop
respons
iv
hrv
may
simpli
exacerb
alreadi
exist
unclear
risk
atop
asthma
infanc
increas
ari
affect
develop
immun
system
whether
ari
lead
asthma
develop
children
genet
predisposit
sever
respons
infect
mix
children
asthma
virus
detect
least
exacerb
picornavirus
probabl
hrv
adult
acut
wheez
episod
includ
bronchiol
acut
asthma
frequent
epidem
season
lrt
manifest
urt
respiratori
viru
infect
children
age
especi
first
year
life
bacteria
major
factor
wheez
exacerb
wheez
blame
high
socioeconom
healthcar
cost
overus
antibiot
primari
caus
hospit
among
children
rare
death
tradit
hrsv
infect
often
viru
causal
associ
expiratori
wheez
wheezi
bronchiti
asthma
exacerb
viru
wellknown
abil
infect
lrt
frequent
detect
studi
low
perceiv
likelihood
urt
virus
hrv
replic
warmer
lrt
nonetheless
period
epidem
wheez
absenc
high
rate
hrsv
detect
common
hrv
even
predomin
culturebas
studi
wheez
coast
studi
use
sampl
criteria
intent
design
investig
role
hrsv
ill
instead
indic
hrv
import
predictor
subsequ
wheez
earli
childhood
support
worldwid
asthmat
airway
character
infiltr
eosinophil
cell
cell
atop
background
eosinophilia
common
viru
isol
rate
higher
nonatop
group
cytokin
eosinophil
activ
profil
hrsvinduc
wheez
differ
induc
hrv
significantli
higher
serum
nasal
aspir
hrsv
cytokin
significantli
elev
symptomat
wheez
group
significantli
higher
rate
hrv
detect
obviou
lrt
symptom
common
children
asthma
nonasthmat
popul
exacerb
asthma
often
preced
symptomat
rather
asymptomat
hrv
infect
although
instanc
exacerb
sign
infect
reduc
peak
expiratori
volum
children
especi
associ
detect
respiratori
picornavirus
sever
wheezi
bronchiti
histor
term
describ
acut
ill
preced
ari
character
cough
wheez
breathless
mucou
product
often
posit
viru
mild
diseas
even
use
cultur
found
hrv
predomin
urt
lrt
sputum
contain
bec
combin
respiratori
tract
sampl
bacteria
often
present
ifv
hrv
airway
epitheli
cell
form
physic
barrier
addit
role
immun
surveil
regulatori
control
howev
asthmat
bronchial
epithelium
compromis
incomplet
tight
junction
sensit
airborn
pollut
like
allergen
respiratori
viral
infect
specif
disturb
hrv
infect
reduc
express
level
tight
adheren
junction
protein
asthma
presenc
hrv
induc
ill
often
sever
nonasthmat
associ
significantli
differ
hrv
load
durat
hrv
rna
detect
peopl
asthma
compar
without
hrvc
type
often
detect
seriou
clinic
outcom
hrva
b
although
hospit
may
fewer
hrvc
speci
aom
diagnos
middl
ear
effus
otorrhea
simultan
sign
symptom
ari
includ
fever
earach
rhiniti
cough
sore
throat
chest
wheez
nocturn
restless
irrit
poor
appetit
diarrhea
vomit
transient
abnorm
neg
ear
pressur
upon
tympanometri
occur
twothird
three
quarter
uncompl
cold
among
healthi
children
aom
frequent
reason
outpati
antibiot
therapi
reduc
time
resolut
symptom
infant
attribut
reduc
overal
hospit
burden
aom
sinc
longitudin
daycar
studi
associ
aom
viral
urt
infect
coalesc
clear
aom
often
occur
shortli
viral
ari
frequent
young
occur
often
winter
summer
use
influenza
vaccin
reduc
aom
occurr
third
epidem
period
use
pneumococc
vaccin
reduc
occurr
aom
overal
rel
small
fraction
due
target
bacteria
isol
cultur
pcr
detect
virus
middl
ear
fluid
refractori
natur
aom
case
antibiot
therapi
confirm
virus
play
import
role
ill
studi
reli
underperform
culturebas
techniqu
underestim
role
viral
ari
studi
use
pcr
techniqu
includ
hrv
found
frequent
detect
viru
middl
ear
fluid
nasopharyng
secret
use
pcr
identifi
respiratori
virus
often
hrv
nasal
secret
children
aom
viru
often
detect
nasopharynx
time
middl
ear
fluid
question
relev
pcr
posit
valid
one
picornavirus
detect
nasopharyng
swab
taken
cold
season
aompron
infant
young
children
larg
quantiti
hrv
rna
detect
situ
hybrid
adenoid
tissu
children
recurr
aom
andor
adenoid
hyperplasia
cohort
children
follow
month
use
culturertpcr
hrv
urt
second
frequent
pathogen
associ
aom
hrsv
virus
often
hrv
aom
ari
also
detect
concurr
nonari
period
associ
aom
episod
aom
without
ari
suggest
aom
may
manifest
hrv
ari
wheez
sometim
unit
state
subject
enrol
follow
birth
cohort
first
aom
episod
month
age
hrv
account
virus
detect
specimen
singl
viru
detect
domin
maintain
even
influenza
pandem
daycar
aom
studi
mention
primari
acquisit
streptococcu
pneumonia
haemophilu
influenza
minim
import
initi
factor
aom
effus
nasopharyng
colon
import
anim
studi
shown
virusbacteria
interact
role
nasopharyng
colon
aom
develop
posit
correl
made
hrv
detect
aompron
children
moraxella
catarrhali
infect
well
tendenc
toward
copres
streptococcu
pneumonia
presenc
shown
increas
adher
pneumonia
human
tracheal
epitheli
cell
cultur
believ
three
bacteri
pathogen
colon
without
symptom
viral
ari
shift
balanc
toward
cytokinemedi
inflammatori
state
disord
older
patient
encompass
emphysema
alveolar
destruct
chronic
bronchiti
larg
airway
inflamm
chronic
mucou
product
describ
longterm
obstruct
airflow
lung
compar
asthma
revers
obstruct
normal
flow
exacerb
bacteria
found
half
exacerb
antibiot
therapi
often
yield
poor
outcom
hrv
infect
result
copd
exacerb
case
viru
identifi
date
experiment
human
model
hrv
infect
copd
provid
preliminari
evid
hrv
caus
exacerb
viral
cultur
associ
symptomat
hrv
infect
exacerb
among
chronic
bronchit
includ
case
isol
sputum
lrt
sampl
absenc
hrv
urt
ad
measur
inflammatori
marker
serum
like
improv
speed
predict
infecti
etiolog
exacerb
copd
pneumonia
diseas
often
occur
earli
life
respons
million
death
year
caus
viral
andor
bacteri
infect
diagnosi
pneumonia
requir
radiolog
confirm
inflammatori
infiltr
lung
tissu
childhood
communityacquir
pneumonia
cap
common
develop
countri
cap
also
complic
exist
chronic
medic
condit
take
advantag
immunosenes
role
hrv
contribut
develop
bacteri
pneumonia
like
underestim
determin
etiolog
confound
rariti
obtain
lrt
specimen
shortterm
studi
complex
milieu
virus
bacteria
involv
less
invas
sampl
urt
permit
routin
sampl
screen
conveni
reduc
risk
led
detect
put
pathogen
urt
gener
assumpt
account
lrt
diseas
especi
children
age
year
pneumonia
studi
complic
lack
suitabl
control
group
sputum
produc
healthi
lower
airway
needl
aspir
gold
standard
also
hospit
procedur
risk
studi
comprehens
use
sensit
molecular
test
also
rare
studi
cap
etiolog
use
cap
investig
pcr
method
almost
doubl
microbiolog
diagnos
convent
cultur
serolog
techniqu
especi
improv
identif
mix
infect
fastidi
virus
rapid
diagnosi
aid
manag
help
make
decis
treatment
prolong
search
etiolog
agent
lead
invas
test
least
quarter
clinic
cap
case
remain
unsupport
microbiolog
find
infect
caus
pneumonia
vari
age
vaccin
statu
virus
detect
infant
month
age
pneumonia
case
follow
season
pattern
bacteria
also
detect
infant
older
children
elderli
sever
cap
studi
predat
use
pcr
pronounc
hrsv
follow
hrv
major
viral
contributor
cap
virus
compris
childhood
pneumonia
case
pcr
age
role
hrv
receiv
increas
attent
increasingli
major
viral
group
detect
urt
lrt
sputum
specimen
children
cap
hold
true
even
studi
extend
across
year
presum
would
account
season
variat
viru
preval
suspect
virus
hrv
prepar
way
subsequ
bacteri
infect
direct
indirect
fashion
laboratori
data
support
well
observ
data
show
high
proport
hrvbacteri
codetect
mix
infect
includ
virus
possibl
caus
antibacteri
treatment
failur
sometim
puzzl
physician
mix
infect
occur
frequent
lrt
diseas
pneumonia
surpris
sinc
new
techniqu
make
clear
lung
steril
environ
thought
viralbacteri
coinfect
compris
patient
viralvir
bacterialbacteri
much
less
common
hrsv
hrv
often
codetect
pneumonia
urt
sampl
hrv
detect
domin
younger
children
pneumonia
peak
hrv
season
although
frequent
codetect
virus
acut
bronchiti
less
durat
children
defin
sudden
cough
often
result
larg
airway
infect
frequent
involv
virus
croup
laryngotracheobronch
viral
recurr
common
lrt
ill
children
includ
trachea
larynx
well
larger
airway
result
bark
cough
patient
croup
often
viral
infect
role
hrv
although
extent
unclear
despit
test
third
case
remain
without
viral
etiolog
tracheobronch
result
infect
volunt
chest
pain
cough
report
half
adult
hrv
infect
well
children
adult
hrv
detect
exacerb
bronchiti
without
associ
ari
bronchiol
occur
season
especi
winter
infant
month
age
affect
small
peripher
bronchiol
winter
peak
season
hrsv
circul
usual
hrv
bronchiol
clinic
diagnosi
encompass
variou
diseas
entiti
often
report
associ
detect
hrsv
winter
viru
howev
hrv
make
major
hrsvneg
bronchiol
case
hrv
codetect
hrsv
hospit
prolong
compar
case
posit
either
viru
alon
children
posit
hrv
clinic
diagnos
bout
bronchiol
significantli
higher
risk
recurr
wheez
subsequ
year
anoth
viru
detect
hrv
report
fivefold
case
bronchiol
hrsv
among
patient
prospect
cohort
low
birth
weight
infant
bueno
air
argentina
viral
ari
proport
infect
may
complic
sinus
inflamm
sinu
mucosa
extent
may
underestim
children
ari
mild
unattend
parent
symptom
may
includ
sinu
pain
headach
facial
pain
discolor
nasal
discharg
postnas
drip
cough
sore
throat
malais
sometim
fever
children
precis
role
virus
bacteria
sinus
still
unclear
sinus
common
comorbid
asthma
situ
presenc
rna
maxillari
sinu
epithelium
report
seven
adult
acut
sinus
hrv
also
detect
pcr
half
adult
acut
maxillari
sinus
half
hrv
posit
neg
bacteria
common
cold
often
associ
comput
tomograph
confirm
sinu
caviti
occlus
abnorm
adult
selfdiagnos
ari
magnet
reson
imag
identifi
revers
abnorm
paranas
sinus
third
healthi
adult
volunt
follow
challeng
evid
tropism
hrv
sinu
tissu
come
far
success
host
vitro
hrvc
replic
cultur
serologybas
test
shown
viru
infect
cystic
fibrosi
cf
patient
occur
preval
gener
commun
consequ
infect
obviou
sever
includ
deterior
lung
function
cough
increas
expector
weight
loss
synergist
increas
bacteri
growth
acquisit
new
bacteri
infect
mechan
behind
acquisit
new
bacteria
still
unknown
alway
observ
may
involv
reduct
host
immun
respons
viral
damag
respiratori
epithelium
circumstanti
evid
hrv
infect
associ
respiratori
exacerb
cystic
fibrosi
patient
albeit
low
number
nonmolecular
studi
without
significantli
differ
clinic
outcom
nonhrv
ari
patient
molecular
method
yet
appli
regularli
thoroughli
systemat
gener
find
hrv
promin
among
cf
children
ariassoci
respiratori
exacerb
involv
mix
viralbacteri
infect
hand
wash
disinfect
wipe
shown
effect
method
interrupt
transfer
fomit
nose
conjunctiva
howev
eye
rub
face
touch
nosepick
occur
frequent
selfinocul
often
outpac
person
hygien
particularli
young
hand
disinfect
frequent
recommend
prevent
hrv
infect
support
control
clinic
trial
natur
set
despit
good
result
experiment
test
ethanolcontain
disinfect
effect
simpl
hand
wash
soap
water
remov
inoculum
assess
cultur
inclus
organ
acid
afford
residu
antivir
effect
howev
continu
hand
wash
extra
ingredi
result
skin
irrit
experiment
test
may
bias
short
studi
period
absenc
mucu
carrier
mimic
natur
surfac
deposit
overli
stringent
control
viru
applicationhand
disinfect
compar
natur
studi
addit
natur
set
studi
use
pcr
detect
hrv
often
cultur
dispar
outcom
may
also
reflect
contribut
airborn
hrv
transmiss
absenc
vaccin
specif
antivir
popular
method
intervent
uncompl
hrv
ari
treatment
symptom
achiev
use
analges
decongest
antihistamin
antituss
due
lack
studi
data
limit
effect
overthecount
common
cold
medic
children
anticholinerg
agent
proven
use
reduc
rhinorrhea
control
symptom
exacerb
asthma
requir
hospit
bronchodil
oral
corticosteroid
main
treatment
interrupt
proinflammatori
immun
respons
specif
signal
pathway
use
steroid
novel
therapeut
may
prove
robust
approach
treat
hrv
infect
success
hrsv
initi
earli
ill
combin
antivir
antiinflammatori
chlorpheniramin
compon
show
promis
interrupt
nasal
viral
replic
symptom
antivir
agent
tabl
requir
earli
applic
effect
preced
pathogen
immun
respons
hrv
infect
often
fail
reproduc
vitro
success
vivo
antirhinovir
drug
base
capsidbind
agent
fig
addit
oral
deliveri
complic
drug
safeti
rout
increas
risk
system
side
effect
compar
nasal
topic
rout
risk
must
consid
alongsid
diseas
treat
drug
side
effect
disproportion
sever
compar
common
cold
sever
asthma
exacerb
system
rout
benefici
effect
sought
hrv
replic
site
otherwis
inaccess
associ
respiratori
tract
ill
recent
discoveri
new
speci
hrvc
shone
bright
light
littl
known
hrv
hrvc
also
newli
discov
hrva
hrvb
fastidi
cultur
singl
report
hrvc
growth
primari
sinu
tissu
ident
cellular
receptor
still
unknown
thu
difficult
proceed
mani
area
includ
basic
virolog
seroepidemiolog
immunobiolog
antivir
test
determin
receptor
new
hrv
would
aid
search
access
cultur
system
would
great
interest
vaccin
hrv
increas
evid
interact
hrv
host
respiratori
virus
may
wise
interfer
fulli
understand
impact
lose
constantli
circul
hrv
challeng
would
antivir
specif
target
hrv
may
better
bet
routin
hrv
test
genotyp
first
need
widespread
surveil
antivir
resist
import
compon
monitor
success
intervent
studi
determin
whether
differ
clinic
immunobiolog
impact
mani
differ
type
lack
would
greatli
improv
abil
plan
futur
routin
test
understand
clinic
respons
divers
hrv
outbreak
ari
improv
hrv
epidemiolog
interest
note
hrvb
significantli
underrepres
hrv
detect
yet
know
nich
clinic
impact
may
possibl
hrvb
well
adapt
hrv
caus
littl
detect
clinic
impact
may
creat
differ
impact
expect
may
speci
declin
juri
remain
whether
hrv
caus
involv
develop
asthma
mere
trigger
exacerb
asthma
establish
high
healthcar
impact
asthma
around
world
atop
condit
may
exacerb
hrv
rise
import
area
investig
